Dan Weidner
About Dan Weidner
Dan Weidner is the Associate Director of Worldwide Customer & Market Insights, Immuno-Oncology at Bristol Myers Squibb, with extensive experience in healthcare commercial challenges and a background in biopharmaceutical research and development.
Company
Dan Weidner is currently employed at Bristol Myers Squibb where he holds the position of Associate Director, Worldwide Customer & Market Insights, Immuno-Oncology. Prior to this role, he was associated with Celgene. His work focuses on the biopharmaceutical sector, specifically within the domain of immuno-oncology.
Title
Dan Weidner serves as the Associate Director, Worldwide Customer & Market Insights, Immuno-Oncology at Bristol Myers Squibb. In this capacity, he leverages his expertise in market insights and customer analytics to support strategic decision-making processes.
Education and Expertise
Dan Weidner holds an MBA in Marketing and Strategy from the Robert H. Smith School of Business at the University of Maryland, and a BS in Biology from Dickinson College. His extensive experience spans across healthcare commercial challenges including clinical trial design, forecasting, pricing strategy, payer access, patient behavior, competitive product impact, health reform, and message testing. He excels in applying quantitative and qualitative research methodologies to address these challenges.
Background
Dan Weidner's career includes significant roles at various organizations. He worked at InCrowd, Inc as Senior Director, Client Services, at Ipsos as Director, Commercial Strategy & Forecasting, at RG+A as Associate Director, and at Roger Green and Associates as Research Manager and Research Associate. Additionally, he has experience as a Regulatory Specialist and Research Associate at INC Research, and as an MBA Intern at Under Armour in both Men's Brand Marketing and Consumer Insights.
Achievements in Market Insights
Dan Weidner is known for his ability to translate complex analyses and methodologies into client-friendly solutions. He has a proven track record of managing projects and teams within the pharmaceutical, biotech, medical device, and consumer products industries. His work often involves data analytics to enhance precision in therapeutic interventions and he advocates for health equity and improved patient access to care.